Moreover, there is a lack of in vitro studies investigating the potential of biological behaviors such as targeting NRF2 to enhance ferroptosis in esophageal cancer cells and improve radiotherapy outcomes. This evidence concerns the gene NFE2L2 and esophageal cancer.